Carla Valencia, MD ♕♥
@CarlaArgen1
IMG 🇪🇨// PGY-3 IM
Nephrology application ✅ Excited for the journey ahead! Empowering patients through knowledge is key to better outcomes. Grateful for the support of my mentors, my husband, family and residency program. 🫘💕 AAMC: 15610925 #MedTwitter #FellowshipMatch #FellowMatch
One half of our kidney beans from the class of 2026! Watch out for this future Nephrologist! 🫘⭐️@CarlaArgen1 #Nephtwitter #Match2026
Nephrology application ✅ Excited for the journey ahead! Empowering patients through knowledge is key to better outcomes. Grateful for the support of my mentors, my husband, family and residency program. 🫘💕 AAMC: 15610925 #MedTwitter #FellowshipMatch #FellowMatch
In patients with CKD who are non-diabetic, sodium-glucose cotransporter 2 inhibitors (SGLT2i) may slow eGFR decline. Read more: kidney.pub/KID0886 #ASNKidney360
This Core Curriculum explores commonly implicated pathophysiological mechanisms in kidney dysfunction in heart failure and discuss principles behind effective decongestion and assessment of adequacy of natriuresis: bit.ly/434spfa (FREE) @KevinBryanLo @UVoverP @RangaswJ
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease bit.ly/Mazhar25OI #OpenAccess #VisualAbstract @FuEdouard @VladoPerkovic @KatherineTuttl8 @jjcarrero1
Comparing #CystatinC Estimated GFR With #Creatinine Estimated GFR in Acute Kidney Injury Recovery #AKI #VisualAbstract by @krithicism kireports.org/article/S2468-…
I can’t believe how time flies, as I enter my final year of IM residency, I just feel deeply grateful for all the lessons, challenges and meaningful connections I made 🙏🏻✨ #Class2026
In the Literature by Biruh T. Workeneh, @LindaWMoore , and William E. Mitch: Revisiting Protein Restriction in Early CKD: Did We Get it Wrong? bit.ly/AJKD25Workeneh… (FREE) Original article in @JAMANetworkOpen
In this multicohort study of community-dwelling adults ≥60y, higher protein intake was associated with lower mortality in people with mild or moderate chronic kidney disease, suggesting that the benefits of proteins may outweigh the downsides ja.ma/3SEPCPf
PR3-ANCA explained: #MedTwitter #RheumTwitter #nephrology
Surveying the Medical Education Landscape: Perspectives on Nephrology Education Among Internal Medicine Residents bit.ly/4jZHPaR (FREE) @cltamargo @stephensozio @hopkinsneph
Understanding how diabetes affects the kidneys and exploring new treatment options is of critical importance. We present a special collection of articles on Diabetes and Kidney Disease: bit.ly/3wpQ6vg (FREE until July 1, 2025)
The May 2025 issue is available now! Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters: bit.ly/May25PLS
I started a new blog about kidney disease and some of the many ways that chronic kidney disease can be slowed down. Have a look and sign up!! kidneystronger.com
Glomerular Filtration of Creatinine: Validation of a Novel Index of Muscle Mass Among Older Adults bit.ly/4a1CdZ4 @LAInker @Htighiouart @runolfpa @ASLtufts @TuftsMCKidney #VisualAbstract
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials bit.ly/Chen25OI #OpenAccess @jefflaintuh #VisualAbstract
So happy and grateful for presenting interesting cases in the NKF 2025, Boston 👏🏼 #SCM2025
Treatment with SGLT-2 inhibitors provides kidney and cardiovascular protection in patients with advanced chronic kidney disease (CKD). bit.ly/CJASN0693 #ASNCJASN